Aktie 6712 EVER SUPREME BIO TECHNOLOGY CO., LTD
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Ever Supreme Bio Technology Co., Ltd

Aktien

6712

TW0006712003

6712

Schlusskurs Taipei Exchange
Andere Börsenplätze
 00:00:00 13.05.2024 		% 5 Tage % 1. Jan.
191,5 TWD -4,49 % Intraday Chart für Ever Supreme Bio Technology Co., Ltd -7,26 % -2,05 %
08.05. Ever Supreme Bio Technology Co., Ltd gibt die Mitglieder des 3. Vergütungsausschusses bekannt CI
29.03. Ever Supreme Bio Technology Co., Ltd berichtet über die Ergebnisse für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Ever Supreme Bio Technology Co., Ltd Announces Members of the 3rd Remuneration Committee
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Ever Supreme Bio Technology Co., Ltd Announces to Distribute Dividends for the Period January 1, 2023 to December 31, 2023
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Ever Supreme Bio Technology Co., Ltd announces an Equity Buyback for 2,000,000 shares, for TWD 1,070 million.
Ever Supreme Bio Technology Co., Ltd authorizes a Buyback Plan.
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Ever Supreme Bio Technology Co., Ltd Announces Cash Dividend, Payable on June 21, 2023
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Ever Supreme Bio Technology Co., Ltd Announces Phase IIa IND for UMSC01 in Patients with Acute Myocardial Infarction Was Granted Permission by Taiwan FDA
Ever Supreme Bio Technology Co., Ltd Announces Submission of A Phase a IND for UMSC01 in Patients with Acute Myocardial Infarction to Taiwan FDA
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Second Quarter Ended June 30, 2021
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2021
Ever Supreme Bio Technology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 6712 Aktie
  4. Nachrichten Ever Supreme Bio Technology Co., Ltd
  5. Andere Sprachen